Role of P-glycoprotein in the pharmacotherapy of pregnant women
Open Access
- 4 July 2019
- journal article
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 13 (2) , 164-173
Abstract
This review addresses the function of the protein-transporter glycoprotein-P (Pgp, ABCB1 protein) and the expression of its encoding gene MDR1/mdr1 throughout the gestational period in humans and animals. We discuss the relationship between the transporter function and the hormone fluctuations during pregnancy. We cite studies on the association between the MDR1/mdr1 gene polymorphisms and the hemato-placental barrier permeability for Pgp substrates, as well as fetal malformations. Under a separate section, drugs commonly used in pregnant women are characterized in terms of their roles as substrates, inducers or inhibitors of the Pgp transporter.Keywords
This publication has 34 references indexed in Scilit:
- P-glycoprotein expression and localization in the rat uterus throughout gestation and laborReproduction, 2016
- Evolving knowledge of the teratogenicity of medications in human pregnancyAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primateBritish Journal of Pharmacology, 2009
- Effect of Pregnancy on Cytochrome P450 3a and P-Glycoprotein Expression and Activity in the Mouse: Mechanisms, Tissue Specificity, and Time CourseMolecular Pharmacology, 2008
- P-glycoprotein in the placenta: Expression, localization, regulation and functionReproductive Toxicology, 2006
- P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational agesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- Multidrug Resistance Phosphoglycoprotein (ABCB1) in the Mouse Placenta: Fetal Protection1Biology of Reproduction, 2005
- P-glycoprotein expression of the human placenta during pregnancyPlacenta, 2005
- Comparative placental structureAdvanced Drug Delivery Reviews, 1999
- Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterusMolecular Reproduction and Development, 1990